That is why I agree with many posters that a serious BP looking to take us out should understand the implications of the PM results, how the drug works and would be looking to act sooner rather than later.
What is very unclear for me is what the NEU board would deem acceptable at this stage and what they are willing to leave on the table so to speak by not completing all ph2 trials. Then there’s also the impetus to get the drug to market in the shortest time possible for sufferers.
That is why I agree with many posters that a serious BP looking...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.65 |
Change
-0.200(1.06%) |
Mkt cap ! $2.381B | |||
| Open | High | Low | Value | Volume |
| $18.85 | $18.92 | $18.35 | $10.53M | 566.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 45 | $18.64 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.73 | 1500 | 1 |
View Market Depth
| Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
$18.73 |
Change
-0.200 ( 0.73 %) |
||||
| Open | High | Low | Volume | ||
| $18.89 | $18.89 | $18.36 | 91292 | ||
| Last updated 15.59pm 26/04/2024 ? | |||||
| NEU (ASX) Chart |